A concise history of gout and hyperuricemia and their treatment - Test2 - elhamkhani - TriplyDB

A concise history of gout and hyperuricemia and their treatment

A concise history of gout and hyperuricemia and their treatment

http://www.wikidata.org/entity/Q24633751

about

Effects of colchicine on pericardial diseases: a review of the literature and current evidence Renal transport of uric acid: evolving concepts and uncertainties Gouty Arthritis: A Review of Acute Management and Prevention.Colchicine for the treatment of gout.Gout: new insights into an old disease.Multiarticular tophaceous gout with severe joint destruction: a pictorial overview with a twist.Innate and adaptive immune responses to cell death.A Systematic Review of the Economic and Humanistic Burden of Gout.Total saponins from Discorea nipponica makino ameliorate urate excretion in hyperuricemic rats.Efficacy and safety of febuxostat in patients with hyperuricemia and gout.Good Intentions, Unintended Consequences, and Unrealized Benefits.Caffeoylquinic acid derivatives rich extract from Gnaphalium pensylvanicum willd. Ameliorates hyperuricemia and acute gouty arthritis in animal model Genome-wide association study of clinically defined gout identifies multiple risk loci and its association with clinical subtypes Macrophage migration inhibitory factor drives neutrophil accumulation by facilitating IL-1β production in a murine model of acute gout.Role of interleukin-1beta during pain and inflammation.Role of Dual Energy Computed Tomography Imaging in the Diagnosis of Gout The sterile inflammatory response.Intracellular sensing of microbes and danger signals by the inflammasomes.Gouty arthritis: understanding the disease state and management options in primary care.Chronic gout in the elderly.Food, drink, and herbs: alternative therapies and gout.Febuxostat: drug review and update.Structure and function of BCRP, a broad specificity transporter of xenobiotics and endobiotics.Colchicine as an anti-inflammatory and cardioprotective agent.Evaluation of antigout activity of Phyllanthus emblica fruit extracts on potassium oxonate-induced gout rat model Discovery of a Flexible Triazolylbutanoic Acid as a Highly Potent Uric Acid Transporter 1 (URAT1) Inhibitor.Hyperuricemia, the kidneys, and the spectrum of associated diseases: a narrative review.The microbiota in pediatric rheumatic disease: epiphenomenon or therapeutic target?Therapeutic use of colchicine and its derivatives: a patent review.Hyperuricemia, Hypertension, and Chronic Kidney Disease: an Emerging Association.Effects of the Dietary Approaches to Stop Hypertension (DASH) Diet and Sodium Intake on Serum Uric Acid.Computational Lexical Analysis of the Language Commonly Used to Describe Gout.Monosodium urate crystal-induced triggering receptor expressed on myeloid cells 1 is associated with acute gouty inflammation.Asymptomatic Papules and Subcutaneous Nodules as First Sign of Gout.Paleopathology and Nutritional Analysis of a South German Monastery Population.Microwave Heating of Crystals with Gold Nanoparticles and Synovial Fluid under Synthetic Skin Patches.Synthesis and biological activity of pyrazolo[3,4-d]thiazolo[3,2-a]pyrimidin-4-one derivatives: in silico approach.Arctium minus crude extract presents antinociceptive effect in a mice acute gout attack model.Interleukin 6 Present in Inflammatory Ascites from Advanced Epithelial Ovarian Cancer Patients Promotes Tumor Necrosis Factor Receptor 2-Expressing Regulatory T Cells.TSPO PET Imaging: From Microglial Activation to Peripheral Sterile Inflammatory Diseases?

P2860

Q26741036-04423739-0689-44B3-B0AB-0C8A90AAFC57 Q26829446-A6DB63CF-8DF4-4789-BB61-951D04818747 Q30249531-AE0FB380-A327-4573-A8EB-048C5306E8A4 Q33738046-ECEF40D3-D45A-4A1C-BB73-79758F236EE2 Q34569614-911168EA-173A-402A-8128-976350983FE4 Q34591561-C4A76335-B33F-481B-B0B3-6DB0F1CD40EA Q35205885-2E973398-EDC9-4A9C-85CE-48FF1AC01F13 Q35629910-969A8A35-E9ED-41F0-873D-5D9480CBC842 Q35910341-34A0CE21-90B8-4E60-8BEF-F6580875BAD4 Q36059557-0CD55EE7-F081-4440-95F0-B5699D0AC5AE Q36199409-07E044DE-D789-4E5C-8A38-DDE360BCAB5D Q36407986-F260B3DD-C5A7-4893-B50D-D23D4BDD1ED3 Q36761933-2302A350-BBEF-4750-9A4A-56331C4CC195 Q37111278-CF24E499-AE51-44E3-9AED-D166AAF1880D Q37376506-69ABEFAA-056F-4012-9095-F3CA59F9C0DE Q37653190-43729F41-E771-4972-96F2-EA9BA926FC58 Q37716003-69C991B9-03DF-4A7B-B2D5-120302712D3A Q37925070-C69F29E0-59BF-492B-8196-6BF29F786A19 Q37926938-A365F5D1-130D-45D6-B32E-AE7450AF0CAD Q38112326-C4576C6D-317A-4806-A9C7-A5275954C60A Q38187008-CE24A94E-0848-41C7-BBF5-F749B5DFB342 Q38200657-48DA1CB6-7B9C-409E-A357-3B64A8412030 Q38207943-9A96A58F-FC6E-4FB8-9A55-090252FD39D7 Q38560160-0FAB795E-B4A1-4C02-AC5C-532765F489C9 Q38722214-DC6D1F33-4DAB-45F6-9750-23EFA29E19D5 Q38730721-A031EA8A-42A1-408F-8CFF-F936F5861570 Q38810539-CE230E4F-E5CC-4D23-87BD-CFBE31187681 Q38861278-E9956076-45B2-428E-9142-A532C4A2666C Q38907453-8F422FE1-FE44-4893-A6EF-9C6550BC5D8A Q38970541-C90A18B1-1203-4F89-BEB1-1BA3733113C7 Q39491406-A3B714F7-B5B7-406B-B2D1-BD7A04147BD7 Q40491609-6E103912-0A9B-428D-A678-1AA42D0D93FF Q41025986-B2AA0B4E-B0B6-4475-B232-AB7975610A3D Q41179803-D1E01A63-04D1-4824-A6A3-F38C26E5324A Q41900298-26A837C6-C46F-410D-83FA-E5E36042D411 Q42188905-191BDFAD-CEC8-43BA-A3D5-DE3A2C5E837F Q43225837-E9458018-00A9-4026-8C02-76753A53D958 Q46322024-5784CCA2-D79F-4DC3-9DB6-BCBC65FC2CF5 Q47121377-D1D38D40-3A0A-4535-8D2B-D880EAE2F2EA Q47123805-3D4A4D3B-54C4-41D5-8F70-CEE3A2E34B02

P2860

A concise history of gout and hyperuricemia and their treatment

http://www.wikidata.org/entity/Q24633751

description

2006 nî lūn-bûn

@nan

2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

A concise history of gout and hyperuricemia and their treatment

@ast

A concise history of gout and hyperuricemia and their treatment

@en

A concise history of gout and hyperuricemia and their treatment

@nl

type

label

A concise history of gout and hyperuricemia and their treatment

@ast

A concise history of gout and hyperuricemia and their treatment

@en

A concise history of gout and hyperuricemia and their treatment

@nl

prefLabel

A concise history of gout and hyperuricemia and their treatment

@ast

A concise history of gout and hyperuricemia and their treatment

@en

A concise history of gout and hyperuricemia and their treatment

@nl

P1433

Q24633751-D65F83F5-D1C8-42B8-AA94-5C10A46D6E34

P1476

Q24633751-A684BA53-EEB1-46BB-A3EF-5FACDE73712D

P2093

Q24633751-97809E56-5BEE-41D1-8797-47C4BBCEE1A4

Q24633751-D59F93D5-18F0-48ED-9780-AA43EF58DA25

P2860

Q24633751-015EB74B-68B1-49F6-BBE0-88D877A3D0D7

Q24633751-026C3CFF-4C84-454C-A714-868499031631

Q24633751-24412E72-6A4E-4AE6-9319-C00F8C68EB14

Q24633751-2CB8D5D8-AC85-4743-ABA1-ED2FF6966780

Q24633751-379877ED-5411-47E3-B40B-AB93B16DDFB3

Q24633751-599D5711-FFF0-4BAD-A350-391C07DF6F1D

Q24633751-637CAD74-FA1E-4001-B130-1B593ADBC9A5

Q24633751-9A6EAFD5-18AB-4E9D-8F5A-4590B63AB086

Q24633751-A82EFFB1-BB31-4542-A464-3951A179A767

Q24633751-B7B4420E-216C-4FFD-855D-1684538BD5F7

P2888

Q24633751-4EB0792E-1306-4AA9-A7A1-95F14F698A33

P304

Q24633751-9EFB89AF-C54B-4BAC-9BAF-8BDE1D83A8F6

P31

Q24633751-65359C0F-C5AD-4536-8EBE-68D11CAB1DFC

Q24633751-840C5B36-9142-459F-8A1F-2DCA1F49808A

P3181

Q24633751-253ED29B-9C25-4D03-BB03-F7F667A7844A

P356

Q24633751-549B52AF-C964-4F47-BC8C-C33080E2EC19

P407

Q24633751-B58C925D-BBAB-4424-8A40-B9915FE0C8B7

P433

Q24633751-EFBE1C8A-E1CF-4771-BD83-09ABB95426B1

P478

Q24633751-7B230E77-427F-4E29-8C7F-8680DA519918

P577

Q24633751-FA885227-C3D5-4796-BA1F-65F2AD49D26E

P5875

Q24633751-19C4F59E-FA65-4943-AE80-FC50257FC41C

P6179

Q24633751-3A901E41-C383-4364-A580-0FE35263DCA5

P698

Q24633751-3E925CDF-15CD-4289-9FCB-87E135F4317A

P921

Q24633751-81A983C5-9BF7-460B-B6C1-9BFA2AF5685B

Q24633751-EFB5A6E3-8A99-47B4-8365-27853EFC7E44

P932

Q24633751-1A2CE7D3-8CEA-408C-B0D0-F6C2D6759A71

P3181

P356

P1433

Arthritis Research and Therapy

P1476

A concise history of gout and hyperuricemia and their treatment

@en

P2093

George Nuki

http://www.w3.org/2001/XMLSchema#string

Peter A Simkin

http://www.w3.org/2001/XMLSchema#string

P2860

Enzyme Defect Associated with a Sex-Linked Human Neurological Disorder and Excessive Purine Synthesis

Pharmacology of uricosuric drugs.

Uric acid production in gout.

Purine-rich foods, dairy and protein intake, and the risk of gout in men.

Febuxostat, a novel nonpurine selective inhibitor of xanthine oxidase: a twenty-eight-day, multicenter, phase II, randomized, double-blind, placebo-controlled, dose-response clinical trial examining safety and efficacy in patients with gout.

Identification of urate crystals in gouty synovial fluid.

The significance of calcium phosphate crystals in the synovial fluid of arthritic patients: the "pseudogout syndrome". II. Identification of crystals.

Febuxostat compared with allopurinol in patients with hyperuricemia and gout.

Study of the paradoxical effects of salicylate in low, intermediate and high dosage on the renal mechanisms for excretion of urate in man.

Observations on certain pathological conditions of the blood and urine, in gout, rheumatism, and Bright's disease

P2888

P304

S1

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4627141

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/AR1906

http://www.w3.org/2001/XMLSchema#string

P407

P433

Suppl 1

http://www.w3.org/2001/XMLSchema#string

P478

8 Suppl 1

http://www.w3.org/2001/XMLSchema#string

P577

2006-04-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6965018

http://www.w3.org/2001/XMLSchema#string

P6179

1038608266

http://www.w3.org/2001/XMLSchema#string

P698

16820040

http://www.w3.org/2001/XMLSchema#string

P921

P932

3226106

http://www.w3.org/2001/XMLSchema#string